6-MEMBERED HETEROCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE

Details for Australian Patent Application No. 2002334854 (hide)

Owner PHARMACIA CORPORATION

Inventors SOUTH, Michael, S.; WEBBER, Ronald, K.; HUANG, Horng-Chih; TOTH, Mihaly, V.; MOORMANN, Alan, E.; SNYDER, Jeffery, S.; SCHOLTEN, Jeffrey, A.; GARLAND, Danny, J.; RUEPPEL, Melvin, L.; NEUMANN, William, L.; LONG, Scott; WEI, Huang; TRUJILLO, John; PARLOW, John, J.; JONES, Darin, E.; CASE, Brenda; HAYES, Michael, J.

Pub. Number AU-A-2002334854

PCT Number PCT/US02/31769

PCT Pub. Number WO2003/029216

Priority 60/332,857 06.11.01 US; 60/350,052 07.11.01 US; 60/332,107 21.11.01 US; 60/331,891 21.11.01 US; 60/326,721 03.10.01 US; 60/338,623 24.10.01 US

Filing date 3 October 2002

Wipo publication date 14 April 2003

International Classifications

C07D 211/98 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/45 - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

C07D 239/22 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/10 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 253/06 Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 211/56 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 213/73 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 237/02 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 031/535 - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/332,857 06.11.01 US; 60/350,052 07.11.01 US; 60/332,107 21.11.01 US; 60/331,891 21.11.01 US; 60/326,721 03.10.01 US; 60/338,623 24.10.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002334854

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002334855-METHOD AND APPARATUS FOR ACQUIRING PILOTS OVER CODE SPACE AND FREQUENCY ERRORS IN A CDMA COMMUNICATION SYSTEM

2002334853-CHEMICAL PURIFICATION CARTRIDGE